Zimmer Biomet (ZBH) Competitors $101.84 -0.51 (-0.50%) As of 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ZBH vs. GEHC, PHG, SOLV, SNN, PEN, STVN, GKOS, NARI, INSP, and BLCOShould you be buying Zimmer Biomet stock or one of its competitors? The main competitors of Zimmer Biomet include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Solventum (SOLV), Smith & Nephew (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and Bausch + Lomb (BLCO). These companies are all part of the "medical equipment" industry. Zimmer Biomet vs. GE HealthCare Technologies Koninklijke Philips Solventum Smith & Nephew Penumbra Stevanato Group Glaukos Inari Medical Inspire Medical Systems Bausch + Lomb Zimmer Biomet (NYSE:ZBH) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, community ranking, profitability, media sentiment, earnings, risk and valuation. Is ZBH or GEHC more profitable? Zimmer Biomet has a net margin of 11.77% compared to GE HealthCare Technologies' net margin of 10.13%. GE HealthCare Technologies' return on equity of 25.74% beat Zimmer Biomet's return on equity.Company Net Margins Return on Equity Return on Assets Zimmer Biomet11.77% 12.99% 7.58% GE HealthCare Technologies 10.13%25.74%6.29% Do analysts rate ZBH or GEHC? Zimmer Biomet presently has a consensus price target of $124.15, suggesting a potential upside of 21.91%. GE HealthCare Technologies has a consensus price target of $97.73, suggesting a potential upside of 51.77%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Zimmer Biomet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 2 Sell rating(s) 11 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.32GE HealthCare Technologies 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75 Do institutionals & insiders hold more shares of ZBH or GEHC? 88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 1.0% of Zimmer Biomet shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, ZBH or GEHC? Zimmer Biomet has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, meaning that its share price is 14% more volatile than the S&P 500. Does the media prefer ZBH or GEHC? In the previous week, GE HealthCare Technologies had 7 more articles in the media than Zimmer Biomet. MarketBeat recorded 25 mentions for GE HealthCare Technologies and 18 mentions for Zimmer Biomet. Zimmer Biomet's average media sentiment score of 1.49 beat GE HealthCare Technologies' score of 1.31 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 12 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 18 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor ZBH or GEHC? Zimmer Biomet received 878 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 67.06% of users gave Zimmer Biomet an outperform vote while only 61.90% of users gave GE HealthCare Technologies an outperform vote. CompanyUnderperformOutperformZimmer BiometOutperform Votes90467.06% Underperform Votes44432.94% GE HealthCare TechnologiesOutperform Votes2661.90% Underperform Votes1638.10% Which has higher earnings & valuation, ZBH or GEHC? GE HealthCare Technologies has higher revenue and earnings than Zimmer Biomet. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZimmer Biomet$7.68B2.64$903.70M$4.4522.89GE HealthCare Technologies$19.67B1.50$1.99B$4.3314.87 Is ZBH or GEHC a better dividend stock? Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Zimmer Biomet pays out 21.6% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. SummaryZimmer Biomet beats GE HealthCare Technologies on 12 of the 21 factors compared between the two stocks. Remove Ads Get Zimmer Biomet News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZBH vs. The Competition Export to ExcelMetricZimmer BiometSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$20.27B$8.66B$5.35B$18.52BDividend Yield0.94%1.74%5.11%4.25%P/E Ratio22.8918.7321.6531.06Price / Sales2.6472.35376.3226.47Price / Cash7.8519.6738.1517.54Price / Book1.634.856.444.29Net Income$903.70M$284.66M$3.20B$1.02B7 Day Performance-2.68%7.48%6.67%4.23%1 Month Performance-7.50%-0.93%-6.27%-6.79%1 Year Performance-18.19%-22.80%8.56%-0.03% Zimmer Biomet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZBHZimmer Biomet4.3774 of 5 stars$101.84-0.5%$124.15+21.9%-17.8%$20.27B$7.68B22.8918,000News CoveragePositive NewsGEHCGE HealthCare Technologies4.2122 of 5 stars$60.98+0.8%$97.73+60.3%-27.2%$27.89B$19.67B14.0850,000Short Interest ↓Positive NewsHigh Trading VolumePHGKoninklijke Philips2.9926 of 5 stars$21.75-1.5%N/A+16.7%$20.44B$18.02B-25.8978,200News CoveragePositive NewsHigh Trading VolumeSOLVSolventum1.6609 of 5 stars$65.25-1.4%$79.86+22.4%+5.5%$11.29B$8.25B23.7322,000Positive NewsSNNSmith & Nephew2.3685 of 5 stars$25.71-2.3%$27.00+5.0%+8.7%$11.24B$5.81B11.9020,100News CoveragePositive NewsGap DownHigh Trading VolumePENPenumbra3.8658 of 5 stars$263.59+0.5%$294.47+11.7%+25.3%$10.15B$1.19B775.253,900Analyst ForecastShort Interest ↑Gap UpSTVNStevanato Group1.4377 of 5 stars€19.23+1.1%N/A-25.7%$5.82B$1.10B40.914,650GKOSGlaukos4.5853 of 5 stars$85.87+2.7%$163.25+90.1%-8.3%$4.86B$383.48M-29.92780Analyst ForecastPositive NewsGap DownHigh Trading VolumeNARIInari Medical0.3454 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800INSPInspire Medical Systems4.6438 of 5 stars$149.72+5.5%$226.70+51.4%-36.5%$4.46B$802.80M86.541,246News CoveragePositive NewsGap DownBLCOBausch + Lomb3.969 of 5 stars$11.86-2.1%$18.82+58.7%-20.0%$4.18B$4.79B-13.0312,500Gap Down Remove Ads Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Solventum Competitors Smith & Nephew Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors Inspire Medical Systems Competitors Bausch + Lomb Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ZBH) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zimmer Biomet Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zimmer Biomet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
